In vivo inhibition of nitric oxide synthase impairs upregulation of contractile protein mRNA in overloaded plantaris muscle

Journal of Applied Physiology

Volumn 100, Issue 1, 2006, Pages 258-265

  Sellman, Jeff E ^a   DeRuisseau, Keith C ^a   Betters, Jenna L ^a   Lira, Vitor A ^a   Soltow, Quinlyn A ^a   Selsby, Joshua T ^a   Criswell, David S ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

1 (2 trifluoromethyl phenyl) imidazole; Functional overload; Insulin like growth factor I; NG nitro L arginine methyl ester; p70 S6 kinase

Indexed keywords

1 (2 TRIFLUOROMETHYLPHENYL)IMIDAZOLE; ALPHA ACTIN; MESSENGER RNA; MYOSIN HEAVY CHAIN ALPHA; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; S6 KINASE; SCATTER FACTOR; VASCULOTROPIN; CONTRACTILE PROTEIN; ENZYME INHIBITOR; SOMATOMEDIN C;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME INHIBITION; IN VIVO STUDY; MALE; NONHUMAN; PLANTARIS MUSCLE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UPREGULATION; ANIMAL; ANKLE; CUMULATIVE TRAUMA DISORDER; DRUG ANTAGONISM; GENETICS; INJURY; METABOLISM; MUSCLE ATROPHY; PATHOPHYSIOLOGY; SKELETAL MUSCLE; SPRAGUE DAWLEY RAT;

ANIMALS; ANKLE JOINT; CONTRACTILE PROTEINS; CUMULATIVE TRAUMA DISORDERS; ENZYME INHIBITORS; INSULIN-LIKE GROWTH FACTOR I; MALE; MUSCLE, SKELETAL; MUSCULAR ATROPHY; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

EID: 33644827045     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00936.2005     Document Type: Article

References (41)

1. Adams GR. Role of insulin-like growth factor-I in the regulation of skeletal muscle adaptation to increased loading. Exerc Sport Sci Rev 26: 31-60, 1998.
2. Adams GR and Haddad F. The relationships among IGF-I, DNA content, and protein accumulation during skeletal muscle hypertrophy. J Appl Physiol 81: 2509-2516, 1996.
3. Adams GR and McCue SA. Localized infusion of IGF-I results in skeletal muscle hypertrophy in rats. J Appl Physiol 84: 1716-1722, 1998.
4. Anderson J and Pilipowicz O. Activation of muscle satellite cells in single-fiber cultures. Nitric Oxide 7: 36-41, 2002.
5. Bodine SC, Stitt TN, Gonzalez M, Kline WO, Stover GL, Bauerlein R, Zlotchenko E, Scrimgeour A, Lawrence JC, Glass DJ, and Yancopoulos GD. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol 3: 1014-1019, 2001.
6. Carson JA, Schwartz RJ, and Booth FW. SRF and TEF-1 control of chicken skeletal alpha-actin gene during slow-muscle hypertrophy. Am J Physiol Cell Physiol 270: C1624-C1633, 1996.
7. Chang WJ, Iannaccone ST, Lau KS, Masters BS, McCabe TJ, McMillan K, Padre RC, Spencer MJ, Tidball JG, and Stull JT. Neuronal nitric oxide synthase and dystrophin-deficient muscular dystrophy. Proc Natl Acad Sci USA 93: 9142-9147, 1996.
8. G-nitro-Larginine methyl ester in vivo. Nitric Oxide 4: 85-93, 2000.
9. Criswell DS, Booth FW, DeMayo F, Schwartz RJ, Gordon SE, and Fiorotto ML. Overexpression of IGF-I in skeletal muscle of transgenic mice does not prevent unloading-induced atrophy. Am J Physiol Endocrinol Metab 275: E373-E379, 1998.
10. Dedkov EI, Kostrominova TY, Borisov AB, and Carlson BM. Resistance vessel remodeling and reparative angiogenesis in the microcirculatory bed of long-term denervated skeletal muscles. Microvasc Res 63: 96-114, 2002.
11. Degens H, Anderson RK, and Alway SE. Capillarization and vascular endothelial growth factor expression in hypertrophying anterior latissimus dorsi muscle of the Japanese quail. Adv Exp Med Biol 530: 577-585, 2003.
12. Degens H, Moore JA, and Alway SE. Vascular endothelial growth factor, capillarization, and function of the rat plantaris muscle at the onset of hypertrophy. Jpn J Physiol 53: 181-191, 2003.
13. Eu JP, Hare JM, Hess DT, Skaf M, Sun J, Cardenas-Navina I, Sun QA, Dewhirst M, Meissner G, and Stamler JS. Concerted regulation of skeletal muscle contractility by oxygen tension and endogenous nitric oxide. Proc Natl Acad Sci USA 100: 15229-15234, 2003.
14. Friedmann B, Kinscherf R, Borisch S, Richter G, Bartsch P, and Billeter R. Effects of low-resistance/high-repetition strength training in hypoxia on muscle structure and gene expression. Pflügers Arch 446: 742-751, 2003.
15. Gavin TP, Spector DA, Wagner H, Breen EC, and Wagner PD. Nitric oxide synthase inhibition attenuates the skeletal muscle VEGF mRNA response to exercise. J Appl Physiol 88: 1192-1198, 2000.
16. Giger JM, Haddad F, Qin AX, and Baldwin KM. Functional overload increases β-MHC promoter activity in rodent fast muscle via the proximal MCAT (β-e3) site. Am J Physiol Cell Physiol 282: C518-C527, 2002.
17. Goldspink G. Changes in muscle mass and phenotype and the expression of autocrine and systemic growth factors by muscle in response to stretch and overload. J Anat 194: 323-334, 1999.
18. Gregory P, Gagnon J, Essig DA, Reid SK, Prior G, and Zak R. Differential regulation of actin and myosin isoenzyme synthesis in functionally overloaded skeletal muscle. Biochem J 265: 525-532, 1990.
19. Gustafsson T, Ameln H, Fischer H, Sundberg CJ, Timmons JA, and Jansson E. VEGF-A splice variants and related receptor expression in human skeletal muscle following submaximal exercise. J Appl Physiol 98: 2137-2146, 2005.
20. Hornberger TA, Stuppard R, Conley KE, Fedele MJ, Fiorotto ML, Chin ER, and Esser KA. Mechanical stimuli regulate rapamycin-sensitive signalling by a phosphoinositide 3-kinase-, protein kinase B- and growth factor-independent mechanism. Biochem J 380: 795-804, 2004.
21. Husain K. Physical conditioning modulates rat cardiac vascular endothelial growth factor gene expression in nitric oxide-deficient hypertension. Biochem Biophys Res Commun 320: 1169-1174, 2004.
22. Itoh S, Katoh Y, Konishi H, Takaya N, Kimura T, Periasamy M, and Yamaguchi H. Nitric oxide regulates smooth-muscle-specific myosin heavy chain gene expression at the transcriptional level-possible role of SRF and YY1 through CArG element. J Mol Cell Cardiol 33: 95-107, 2001.
23. Jensen L, Pilegaard H, Neufer PD, and Hellsten Y. Effect of acute exercise and exercise training on VEGF splice variants in human skeletal muscle. Am J Physiol Regul Integr Comp Physiol 287: R397-R402, 2004.
24. Koh TJ and Tidball JG. Nitric oxide synthase inhibitors reduce sarcomere addition in rat skeletal muscle. J Physiol 519: 189-196, 1999.
25. Owino V, Yang SY, and Goldspink G. Age-related loss of skeletal muscle function and the inability to express the autocrine form of insulin-like growth factor-1 (MGF) in response to mechanical overload. FEBS Lett 505: 259-263, 2001.
26. Perrin LA, June JE, Rosebury W, Robertson A, Kovesdi I, Bruder JT, Kessler PD, Keiser JA, and Gordon D. Increased revascularization efficacy after administration of an adenovirus encoding VEGF(121). Gene Ther 11: 512-521, 2004.
27. Perrone CE, Fenwick-Smith D, and Vandenburgh HH. Collagen and stretch modulate autocrine secretion of insulin-like growth factor-1 and insulin-like growth factor binding proteins from differentiated skeletal muscle cells. J Biol Chem 270: 2099-2106, 1995.
28. Phelan JN and Gonyea WJ. Effect of radiation on satellite cell activity and protein expression in overloaded mammalian skeletal muscle. Anat Rec 247: 179-188, 1997.
29. Plyley MJ, Olmstead BJ, and Noble EG. Time course of changes in capillarization in hypertrophied rat plantaris muscle. J Appl Physiol 84: 902-907, 1998.
30. Rosenblatt JD, Yong D, and Parry DJ. Satellite cell activity is required for hypertrophy of overloaded adult rat muscle. Muscle Nerve 17: 608-613, 1994.
31. Roy RR, Monke SR, Allen DL, and Edgerton VR. Modulation of myonuclear number in functionally overloaded and exercised rat plantaris fibers. J Appl Physiol 87: 634-642, 1999.
32. Sheehan SM, Tatsumi R, Temm-Grove CJ, and Allen RE. HGF is an autocrine growth factor for skeletal muscle satellite cells in vitro. Muscle Nerve 23: 239-245, 2000.
33. Smith LW, Smith JD, and Criswell DS. Involvement of nitric oxide synthase in skeletal muscle adaptation to chronic overload. J Appl Physiol 92: 2005-2011, 2002.
34. Suzuki S, Yamanouchi K, Soeta C, Katakai Y, Harada R, Naito K, and Tojo H. Skeletal muscle injury induces hepatocyte growth factor expression in spleen. Biochem Biophys Res Commun 292: 709-714, 2002.
35. Takahashi A, Kureishi Y, Yang J, Luo Z, Guo K, Mukhopadhyay D, Ivashchenko Y, Branellec D, and Walsh K. Myogenic Akt signaling regulates blood vessel recruitment during myofiber growth. Mol Cell Biol 22: 4803-4814, 2002.
36. Tatsumi R, Anderson JE, Nevoret CJ, Halevy O, and Allen RE. HGF/SF is present in normal adult skeletal muscle and is capable of activating satellite cells. Dev Biol 194: 114-128, 1998.
37. Tidball JG, Lavergne E, Lau KS, Spencer MJ, Stull JT, and Wehling M. Mechanical loading regulates NOS expression in developing and adult skeletal muscle. Am J Physiol Cell Physiol 275: C260-C266, 1998.
38. Vandenburgh HH, Karlisch P, Shansky J, and Feldstein R. Insulin and IGF-I induce pronounced hypertrophy of skeletal myofibers in tissue culture. Am J Physiol Cell Physiol 260: C475-C484, 1991.
39. Wang Y, Nagase S, and Koyama A. Stimulatory effect of IGF-I and VEGF on eNOS message, protein expression, eNOS phosphorylation and nitric oxide production in rat glomeruli, and the involvement of PI3-K signaling pathway. Nitric Oxide 10: 25-35, 2004.
40. Wong TS and Booth FW. Protein metabolism in rat gastrocnemius muscle after stimulated chronic concentric exercise. J Appl Physiol 69: 1709-1717, 1990.
41. Yang S, Alnaqeeb M, Simpson H, and Goldspink G. Cloning and characterization of an IGF-I isoform expressed in skeletal muscle subjected to stretch. J Muscle Res Cell Motil 17: 487-495, 1996.